Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.71
-0.32 (-3.99%)
At close: Jun 13, 2025, 4:00 PM
7.98
+0.27 (3.50%)
After-hours: Jun 13, 2025, 7:25 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Novel Therapeutics
3.95M
Log In
Log In
Log In
Novel Therapeutics Growth
-74.60%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending